Azadine 50 Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Azacitidine (50mg)
Overview Azadine 50 Injection
Myelodysplastic syndrome (MDS), in its various forms affecting adults, is treated with Azadine 50 Injection. This injectable medication may also address other conditions as directed by a physician. Administered intravenously under professional medical guidance, the dosage and frequency are determined individually by your doctor based on your specific needs and may vary. Strict adherence to your doctor's prescribed regimen is crucial; improper usage carries severe risks. While therapeutic effects might not be immediately apparent (requiring weeks or months), discontinuation should only occur with your doctor's consent. Common side effects, including injection site inflammation, nausea, vomiting, and fatigue, should be reported if problematic or severe. Preventive or mitigating strategies may be available. Vaccination during treatment requires prior physician consultation. Regular monitoring of blood cell counts, along with liver, kidney, and cardiac function, is essential. Prior to commencing treatment, disclose any pre-existing liver or kidney conditions, and all other medications, particularly those for infections, as drug interactions are possible. Azadine 50 Injection is contraindicated during pregnancy and lactation.
Primary Ingredients of Azadine 50 Injection
No text provided to rephrase.
Uses of Azadine 50 Injection
Myelodysplastic syndromes: Blood cancer therapies
Major Benefits of Azadine 50 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Azadine 50 Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Weakness
- Nausea
- Decreased potassium level in blood
- Bruise
- Fever
- Chills
- Diarrhea
- Constipation
How to use Azadine 50 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Azadine 50 Injection works:
Leukemia treatment with Azadine 50 Injection involves disrupting the DNA and RNA of cancerous cells, thus inhibiting their proliferation. This anticancer agent facilitates the healthy development of new blood cells within the bone marrow.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Azadine 50 Injection with alcohol is currently undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Azadine 50 Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Azadine 50 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Azadine 50 Injection may induce adverse reactions, potentially impairing driving ability. Fatigue is one such possible side effect of Azadine 50 Injection, which could similarly impact driving capabilities.
KidneyCAUTION
For individuals with impaired kidney function, Azadine 50 Injection requires careful administration. Dosage modification of Azadine 50 Injection might be necessary. Physician consultation is advised.
LiverCAUTION
For individuals with liver impairment, Azadine 50 Injection requires careful administration and may necessitate dosage modification. Physician consultation is advised. Azadine 50 Injection is contraindicated in patients exhibiting advanced hepatic malignancy.
What if you forget to take Azadine 50 Injection :
NA
Facts to Know About Azadine 50 Injection
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine Nucleoside Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Category | Metabolic Antagonists |
3,018 People bought this recently